This site is intended for healthcare professionals
News

New analysis of ORION 10 and ORION 11 trials shows high consistency in lowering LDL-C in individual response with investigational inclisiran.- Novartis

Read time: 1 mins
Last updated:31th Aug 2020
Published:31th Aug 2020
Condition: Atherosclerotic CV Disease
Type: drug
Register free for full access to medthority.com